News
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...
Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman, who has been with the company for 17 years, will depart in the coming months.
Genentech awards sabbaticals to stave off burnout. To keep creativity alive, both it and Google encourage their scientists and engineers to spend fully 20% of each workweek pursuing pet projects.
Federal regulators on Friday approved Genentech's new, less toxic breast cancer drug that targets a protein found in high levels in about a quarter of patients.
For the Bay Area, the impact of Genentech's sale goes far beyond a change of nameplates on a big local company. Genentech was the region's home-grown luminary, with a leading role in the ...
Genentech’s Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Study ...
Genentech's position, that $89 a share "substantially undervalues" the company, is similar to what ImClone Systems, another biotech leader, told drugmaker Bristol-Myers Squibb last week.
Genentech is considering slow-walking an ovarian cancer therapy to make more money under drug pricing reform.
Genentech is a biotech company with a storied past. But what will happen in its future?
Genentech will withdraw Gavreto from use in the United States for treating a type of thyroid cancer as it was not feasible for the Roche unit to pursue the drug for full approval, its partner ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results